Early cancer diagnosis and artificial intelligence (AI) are both rapidly evolving fields, and in some cases, they converge in crucial ways. Specifically, harnessing the power of AI machine learning has changed how we can identify DNA signatures that predict cancer – as early as stage 1.
Share with
Interviews
Listen to our experts share their latest insights on the oncology and diagnostic landscape.
Justin Chen Li, CEO of Helio Genomics, sits down with Nasdaq’s Kristina Ayanian to discuss how the AI-driven healthcare company on a mission to save lives by developing technology that can detect cancer early from a simple blood draw.
Helio Genomics CEO, Justin Chen Li, Interviewed by Orange County Business Journal about recent research on multimodal epigenetic sequencing analysis (MESA).
Share with
Stay Connected With Us.
Subscribe to our newsletter for the latest updates on our journey to defeat cancer.
